BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7523283)

  • 1. [The autoimmune dermatosis bullous pemphigoid: deposition and activation of plasminogen in affected epidermis].
    Reinartz J; Kramer MD
    Immun Infekt; 1994 Feb; 22(1):20-2. PubMed ID: 7523283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The autoimmune blistering skin disease bullous pemphigoid. The presence of plasmin/alpha 2-antiplasmin complexes in skin blister fluid indicates plasmin generation in lesional skin.
    Kramer MD; Reinartz J
    J Clin Invest; 1993 Aug; 92(2):978-83. PubMed ID: 7688770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen activation in bullous pemphigoid immunohistology reveals urokinase type plasminogen activator, its receptor and plasminogen activator inhibitor type-2 in lesional epidermis.
    Schaefer BM; Jaeger C; Drepper E; Kramer MD
    Autoimmunity; 1996; 23(3):155-64. PubMed ID: 8879451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen activation in lesional skin of Pemphigus vulgaris type Neumann.
    Reinartz J; Näher H; Mai H; Kramer MD
    Arch Dermatol Res; 1993; 284(8):432-9. PubMed ID: 7682051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced association of plasminogen/plasmin with lesional epidermis of bullous pemphigoid.
    Gissler HM; Simon MM; Kramer MD
    Br J Dermatol; 1992 Sep; 127(3):272-7. PubMed ID: 1390172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergy between a plasminogen cascade and MMP-9 in autoimmune disease.
    Liu Z; Li N; Diaz LA; Shipley M; Senior RM; Werb Z
    J Clin Invest; 2005 Apr; 115(4):879-87. PubMed ID: 15841177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of plasmin and its complexes with alpha 2-antiplasmin and alpha 2-macroglobulin on secretion of proteinase and plasminogen inhibitors from peripheral mononuclear cells].
    Zhabin SG; Zorin NA; Musatov MI
    Vopr Med Khim; 1995; 41(3):34-7. PubMed ID: 8585176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmin-like proteinase associated with high molecular weight complexes in blister fluid of bullous pemphigoid.
    Lauharanta J; Salonen EM; Vaheri A
    Acta Derm Venereol; 1989; 69(6):527-9. PubMed ID: 2575330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement and plasminogen: pathways in inflammation.
    Kramer MD; Hänsch GM; Rother KO
    Behring Inst Mitt; 1992 Apr; (91):145-56. PubMed ID: 1524563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of the modified form of human plasminogen by alpha 2-macroglobulin-plasmin complexes.
    Yamamoto J; Okamoto U; Morita S; Asada N; Yamaoka M
    Jpn J Physiol; 1985; 35(6):1013-21. PubMed ID: 2422420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An immunohistochemical study of the distribution of plasminogen and plasminogen activators in bullous pemphigoid.
    Venning VA; Wojnarowska F; Cederholm-Williams S
    Clin Exp Dermatol; 1993 Mar; 18(2):119-23. PubMed ID: 8481985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assay of functional plasminogen in rat plasma applicable to experimental studies of thrombolysis.
    Bangert K; Thorsen S
    Thromb Haemost; 2000 Aug; 84(2):299-306. PubMed ID: 10959704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the effect of plasminogen activator on the interaction between alpha 2-macroglobulin and plasmin.
    Toki N; Takasugi S; Sumi H; Yamura T
    Thromb Haemost; 1978 Oct; 40(2):377-86. PubMed ID: 83685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C3d immunohistochemistry on formalin-fixed tissue is a valuable tool in the diagnosis of bullous pemphigoid of the skin.
    Pfaltz K; Mertz K; Rose C; Scheidegger P; Pfaltz M; Kempf W
    J Cutan Pathol; 2010 Jun; 37(6):654-8. PubMed ID: 19863700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding and activation of plasminogen at the surface of human keratinocytes.
    Reinartz J; Batrla R; Boukamp P; Fusenig N; Kramer MD
    Exp Cell Res; 1993 Sep; 208(1):197-208. PubMed ID: 8359216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A probe of the human plasmin-alpha 2-macroglobulin interaction utilizing monoclonal antibodies to human plasmin.
    Cummings HS; Castellino FJ
    Ann N Y Acad Sci; 1983; 421():143-8. PubMed ID: 6202187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of cell surface receptor-bound plasmin by alpha 2-antiplasmin and alpha 2-macroglobulin.
    Hall SW; Humphries JE; Gonias SL
    J Biol Chem; 1991 Jul; 266(19):12329-36. PubMed ID: 1712017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of external ocular surgery and mode of post-operative care on plasminogen, plasmin, angiostatins and alpha(2)-macroglobulin in tears.
    Lembach M; Linenberg C; Sathe S; Beaton A; Ucakhan O; Asbell P; Sack R
    Curr Eye Res; 2001 Apr; 22(4):286-94. PubMed ID: 11462168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the relative contribution of different protease inhibitors to the inhibition of plasmin in vivo.
    Levi M; Roem D; Kamp AM; de Boer JP; Hack CE; ten Cate JW
    Thromb Haemost; 1993 Feb; 69(2):141-6. PubMed ID: 7681223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of the plasmin system in human mammary pathology using immunofluorescence.
    Clavel C; Chavanel G; Birembaut P
    Cancer Res; 1986 Nov; 46(11):5743-7. PubMed ID: 2428483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.